著者
入谷 修司
出版者
日本神経治療学会
雑誌
神経治療学 (ISSN:09168443)
巻号頁・発行日
vol.33, no.3, pp.409-412, 2016 (Released:2016-11-10)
参考文献数
8

When the patient's chief complaints were not explained in a rational manner based on usual medical examinations, usually those patients tend to be transfer to the psychiatry as being suspicious diagnosed somatoform disorder or psychogenic disease. But the treating these unexplainable clinical conditions in psychiatric category might to be lead to the mind–body dualism in clinical settings. Prominent clinical attitude based on only EBM (evidence based medicine) under ever–improving medical sciences would be attentive mainly to the biomedical model, not on the bio–psycho–social medical model. It has been unknown the precise neural mechanism of psychosomatic correlation even now. Nowadays, we clinicians should confront the patient's complaints with mind–body identity theory and explore their cause of disease as whole–patient approach.
著者
入谷 修司
出版者
日本神経治療学会
雑誌
神経治療学 (ISSN:09168443)
巻号頁・発行日
vol.33, no.3, pp.409-412, 2016

<p>When the patient's chief complaints were not explained in a rational manner based on usual medical examinations, usually those patients tend to be transfer to the psychiatry as being suspicious diagnosed somatoform disorder or psychogenic disease. But the treating these unexplainable clinical conditions in psychiatric category might to be lead to the mind–body dualism in clinical settings. Prominent clinical attitude based on only EBM (evidence based medicine) under ever–improving medical sciences would be attentive mainly to the biomedical model, not on the bio–psycho–social medical model. It has been unknown the precise neural mechanism of psychosomatic correlation even now. Nowadays, we clinicians should confront the patient's complaints with mind–body identity theory and explore their cause of disease as whole–patient approach.</p>
著者
入谷 修司 羽渕 知可子 池田 研二
出版者
日本生物学的精神医学会
雑誌
日本生物学的精神医学会誌 (ISSN:21866619)
巻号頁・発行日
vol.21, no.2, pp.113-119, 2010 (Released:2017-02-16)
参考文献数
18

W.Griesinger(1817-1868)が「精神病は脳病である」“ Geisteskrankheiten sind Gehirnkrankheiten”という有名なテーゼを 150 年以上も前に残し,ドイツを中心に,精神医学は神経学と呼応しながら「精神神経学」として主に脳病理学から病態解明アプローチがなされた。それはひとつにはクレペリン(E. Kraepeline, 1856-1926)やアルツハイマー(A. Alzheimer, 1864-1915)などの業績へと結実した。患者観察から得られる臨床症状と,脳病理を中心とした脳機能とを結びつける臨床神経病理学を中心とした病態解明への努力は,精神疾患の責任病巣や臨床症状の成因に関する大きな手がかりをもたらした。近年の神経画像の技術進歩による脳形態情報や分子生物学的アプローチによって得られた疾患リスク遺伝子の情報などは,いまや「脳」という臓器を共通項として,神経病理学的な知見と収斂する時期を迎えていると考えられる。